Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monica P. Bubenik
Observed names:
Bubenik, M.P.,
Monica Bubenick,
Monica Bubenik
Institution:
Quebec Rehabilitation Research Network
Observed institutions:
Memorial University of Newfoundland,
Quebec Rehabilitation Research Network,
Vertex Pharmaceuticals (Canada)
ORCID:
0000-0002-1449-2312
Observed ORCID:
0000-0002-1449-2312
OpenAlex ID:
A5041339759
Discovery of 4-Aryl-4H-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-Based High Throughput Screening Assay. 4. Structure–Activity Relationships of N-Alkyl Substituted Pyrrole Fused at the 7,8-Positions
2008
·
William Kemnitzer
, John Drewe
, et al.
·
Journal of Medicinal Chemistry
·
209
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Part 5: Modifications of the 2- and 3-positions
2007
·
William Kemnitzer
, Songchun Jiang
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
103
Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ
2022
·
Monica Bubenik
, Pavel Mader
, et al.
·
Journal of Medicinal Chemistry
·
78
A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen
2003
·
Karen Meerovitch
, Frédéric Bergeron
, et al.
·
Vascular Pharmacology
·
66
Synthesis and structural and magnetic properties of mononuclear, dinuclear, and tetranuclear copper(II) complexes of a 17-membered macrocyclic ligand (HM3), capable of forming endogenous phenoxide and pyridazino bridges. X-ray crystal structures of [Cu2(M3)(.mu.2-OMe)(NO3)2], [Cu4(M3)2(.mu.3-OMe)2(.mu.2-Cl)2Cl2], [Cu4(M3)2(.mu.3-OEt)2(.mu.2-N3)2(N3)2](MeOH), [Cu4(M3)2(.mu.3-OMe)2(NCS)4](DMF), and [Cu(M3)(NCS)2]
1993
·
Santokh. S. Tandon
, Laurence K. Thompson
, et al.
·
Inorganic Chemistry
·
47
Novel nucleotide phosphonate analogues with potent antitumor activity
2002
·
Monica Bubenik
, Rabindra Rej
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
35
Tetranuclear, Hexanuclear, and Octanuclear Copper(II) Complexes of a Series of Novel Dendritic Poly(phthalazine) Ligands
1995
·
Yisheng Zhang
, Laurence K. Thompson
, et al.
·
Inorganic Chemistry
·
30
A stereoselective route to bioactive nucleotide phosphonate analogs
2003
·
Monica Bubenik
, Patrice Préville
, et al.
·
Tetrahedron Letters
·
21
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor
2025
·
Frédéric Vallée
, Matias Casás-Selves
, et al.
·
Journal of Medicinal Chemistry
·
15
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic cores
2014
·
James A. Henderson
, Darius Bilimoria
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
13
Thiophene-based vitronectin receptor antagonists
2003
·
Monica Bubenik
, Karen Meerovitch
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
Diastereoselective Arbuzov dealkylation of cobalt(III) perfluoroalkyl prochiral phosphonite complexes
1993
·
Chet R. Jablonski
, Huaizhu Ma
, et al.
·
Organometallics
·
10
Benzimidazole-containing HCV NS5A inhibitors: Effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency
2014
·
James A. Henderson
, Darius Bilimoria
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
8
Products of the addition of 1,4-naphthoquinone to an acecyclone
2007
·
Monica P. Bubenik
, John N. Bridson
, et al.
·
Tetrahedron Letters
·
6
Structure and magnetic properties of a novel tetranuclear copper(II) complex of an extended bis-phthalazine ligand
1993
·
Yisheng Zhang
, Laurence K. Thompson
, et al.
·
Journal of the Chemical Society Chemical Communications
·
6
Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ
2026
·
Monica Bubenik
, Pavel Mader
, et al.
·
ACS Medicinal Chemistry Letters
·
1
Thiophene‐Based Vitronectin Receptor Antagonists
2003
·
Monica Bubenik
, Karen Meerovitch
, et al.
·
ChemInform
·
1
PDF
Abstract 1734: RP-1664: A potent and selective PLK4 inhibitor causing tumor regressions in TRIM37-high xenograft models of solid tumors
2025
·
Elliot Goodfellow
, Frederic Vallee
, et al.
·
Cancer Research
CCDC 298099: Experimental Crystal Structure Determination
2007
·
Bubenik, M.P.
, Bridson, J.N.
, et al.
·
The Cambridge Structural Database
Novel Nucleotide Phosphonate Analogues with Potent Antitumor Activity.
2003
·
Monica Bubenik
, Rabindra Rej
, et al.
·
ChemInform
Show more works
View as search
Works count:
20
Citation count:
661
H-index:
11
I10-index:
12
Year
Topic
Type